5Genuth S, Alberti KG, Bennett P, et al. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care, 2003,26:3160-3167.
6Unwin N, Shaw J, Zimmet P, et al. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med, 2002,19:708-723.
7The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care, 2004,27:S5-S10.
8Gu D, Reynolds K, Duan X, et al. InterASIA Collaborative Group. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia, 2003,46:1190-1198.
9Tai ES, Goh SY, Lee JJ, et al. Lowering the criterion for impaired fasting glucose: impact on disease prevalence and associated risk of diabetes and ischemic heart disease. Diabetes Care, 2004,27:1728-1734.
10Gabir MM, Hanson RL, Dabelea D, et al. Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes. Diabetes Care, 2000,23:1113-1118.
3Lindstr m J.Sustained reduction in the incidence of type 2diabetes by lifestyle intervention:followup of the FinnishDiabetes Prevention Study[J].Lancet,2006,368(9543):1673-1679.
4DeFronzo RA.Banting Lecture:from the triumvirate to theominous octet:a new paradigm for the treatment of type 2diabetes mellitus[J].Diabetes,2009,58(4):773-795.
5Holman R R,Paul SK,Bethel MA,et al.10-Year follow-upof intensive glucose control in type 2 diabetes[J].N Engl JMed,2008,359:1577-1589.
6Nathan DM,Cleary PA,Backlund JY,et al.Intensive diabetestreatment and cardiovascular disease in patients with type 2diabetes[J].N Engl J Med,2005,353(25):2643-2653.
7Knowler WC,Barrett-Connor E,Fowler SE,et al.Reduction inthe incidence of type 2 diabetes with lifestyle intervention ormetformin[J].N Engl J Med,2002,346(6):393-403.
8Xiang AH,Peters RK,Kjos SL,et al.Effect of pioglitazone onpancreatic beta-cell function and diabetes risk in Hispanicwomen with prior gestational diabetes[J].Diabetes,2006,55(2):517-522.
9Gerstein HC,Yusuf S,Bosch J,et al.Effect of rosiglitazone onthe frequency of diabetes in patients with impaired glucosetolerance or impaired fasting glucose:a randomised controlledtrial[J].Lancet,2006,368(9541):1096-1105.
10Matsuda M,DeFronzo RA.Insulin sensitivity indices obtainedfrom oral glu cose tolerance testing:comparison with theeuglycemic insulin clamp[J].Diabetes Care,1999,22(9):1462-1470.
